Haiming Yu

Area of research

Epidemiology · Pulmonary and Respiratory Medicine

Research interest

Research focused on Anaplastic lymphoma kinase and Bronchiolitis, with related work in Colorectal cancer, Recombinant DNA, Breastfeeding. Notable publications include 'The effect of recombinant human interferon α1b treatment of infants hospitalized with lower respiratory tract infection on subsequent wheezing', 'Anaplastic Lymphoma Kinase (ALK) Inhibitors Show Activity in Colorectal Cancer With ALK Rearrangements: Case Series and Literature Review', and 'A Multicentre Preliminary Study of the Effect of Recombinant Human Interferon α1b Treatment of Infants Hospitalized with Lower Respiratory Tract Infection on Subsequent Wheezing'.

h-index

—

citations

works

NIH funding

—

primary concept

—

✉ Find email ↗

Recent publications

Anaplastic Lymphoma Kinase (ALK) Inhibitors Show Activity in Colorectal Cancer With ALK Rearrangements: Case Series and Literature Review

The Oncologist 2024cited by 6position: middledoi

The effect of recombinant human interferon α1b treatment of infants hospitalized with lower respiratory tract infection on subsequent wheezing

Jornal de Pediatria 2021cited by 7position: middledoi

A Multicentre Preliminary Study of the Effect of Recombinant Human Interferon α1b Treatment of Infants Hospitalized with Lower Respiratory Tract Infection on Subsequent Wheezing

2020cited by 1position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Looking for a research collaborator?

Search millions of scientists by field, institution, impact, and funding status — see their work, find their email, and reach out directly.

Find collaborators in Epidemiology · Pulmonary and Respiratory Medicine →